Recipharm's financial objectives and strategies 

Recipharm’s objective is to be a world leading supplier of CDMO services:

• one of the top three suppliers in Europe in 2013

• one of the top three suppliers in the world in 2015

The financial objectives are:
• average annual sales growth higher than 15% over a business cycle, of which 5-10% will come from organic growth
• return on capital employed higher than 20% per year
• net debt to equity of less than 0.5

These will be achieved through:
• organic growth by leveraging Recipharm’s resources and capabilities across the CDMO market
• additional growth from selected acquisitions that support, differentiate and develop the Company’s competitive position
• highly efficient operations
• increased contribution of own technology and IP to total sales

 

Investor contact 

Björn Westberg
T: +46 8 602 52 00